Development of integrase inhibitors for treatment of AIDS: An overview
- 30 January 2007
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 42 (9) , 1159-1168
- https://doi.org/10.1016/j.ejmech.2007.01.024
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Novel HIV-1 Integrase Inhibitors Derived from Quinolone AntibioticsJournal of Medicinal Chemistry, 2006
- 6-Aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assaysBioorganic & Medicinal Chemistry Letters, 2004
- Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activityBioorganic & Medicinal Chemistry Letters, 2004
- (−)-Arctigenin as a Lead Structure for Inhibitors of Human Immunodeficiency Virus Type-1 IntegraseJournal of Medicinal Chemistry, 1996
- Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractionsBiochemical and Biophysical Research Communications, 1992
- Antiretroviral activities of anthraquinones and their inhibitory effects on reverse transcriptaseAntiviral Research, 1991
- Aryl-2 et alkyl-2 quinoléines nouvelles isolées d'une Rutacée bolivienne: GalipealongifloraCanadian Journal of Chemistry, 1989
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983